Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10691920rdf:typepubmed:Citationlld:pubmed
pubmed-article:10691920lifeskim:mentionsumls-concept:C0019693lld:lifeskim
pubmed-article:10691920lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:10691920lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:10691920lifeskim:mentionsumls-concept:C0021081lld:lifeskim
pubmed-article:10691920lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:10691920lifeskim:mentionsumls-concept:C1415900lld:lifeskim
pubmed-article:10691920lifeskim:mentionsumls-concept:C0887947lld:lifeskim
pubmed-article:10691920lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10691920pubmed:issue3lld:pubmed
pubmed-article:10691920pubmed:dateCreated2000-4-24lld:pubmed
pubmed-article:10691920pubmed:abstractTextInterferons play an important, but incompletely understood role in HIV-related disease. We investigated the effect of HAART on plasma levels of IFN-alpha, IFN-gamma, neopterin and interferon-inducible protein 10 (IP-10) in 41 HIV-infected patients during 78 weeks of therapy. At baseline HIV-infected patients had raised levels of both IP-10 and IFN-alpha compared with healthy controls (n = 19), with particularly high levels in advanced disease. HAART induced a marked decrease in levels of both IFN-alpha, neopterin and IP-10, though not to normal concentrations. In contrast, IFN-gamma levels were low throughout the study, and not different from controls. While neopterin and IP-10 remained significantly decreased compared with baseline levels throughout the study, IFN-alpha levels returned to baseline at the end of the study. Persistently high IP-10 and IFN-alpha levels were associated with immunological treatment failure and even high baseline levels of IFN-alpha appeared to predict immunological relapse. Furthermore, we found a markedly suppressive effect of exogenously added IFN-alpha on phytohaemagglutinin-stimulated lymphocyte proliferation in both patients and controls, and this suppressive effect seemed not to involve enhanced lymphocyte apoptosis. Our findings suggest a pathogenic role of IFN-alpha in HIV infection, which may be a potential target for immunomodulating therapy in combination with HAART.lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:languageenglld:pubmed
pubmed-article:10691920pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:citationSubsetIMlld:pubmed
pubmed-article:10691920pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10691920pubmed:statusMEDLINElld:pubmed
pubmed-article:10691920pubmed:monthMarlld:pubmed
pubmed-article:10691920pubmed:issn0009-9104lld:pubmed
pubmed-article:10691920pubmed:authorpubmed-author:MüllerFFlld:pubmed
pubmed-article:10691920pubmed:authorpubmed-author:BendtzenKKlld:pubmed
pubmed-article:10691920pubmed:authorpubmed-author:FrølandS SSSlld:pubmed
pubmed-article:10691920pubmed:authorpubmed-author:AukrustPPlld:pubmed
pubmed-article:10691920pubmed:authorpubmed-author:StylianouEElld:pubmed
pubmed-article:10691920pubmed:issnTypePrintlld:pubmed
pubmed-article:10691920pubmed:volume119lld:pubmed
pubmed-article:10691920pubmed:ownerNLMlld:pubmed
pubmed-article:10691920pubmed:authorsCompleteYlld:pubmed
pubmed-article:10691920pubmed:pagination479-85lld:pubmed
pubmed-article:10691920pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:10691920pubmed:meshHeadingpubmed-meshheading:10691920...lld:pubmed
pubmed-article:10691920pubmed:meshHeadingpubmed-meshheading:10691920...lld:pubmed
pubmed-article:10691920pubmed:meshHeadingpubmed-meshheading:10691920...lld:pubmed
pubmed-article:10691920pubmed:meshHeadingpubmed-meshheading:10691920...lld:pubmed
pubmed-article:10691920pubmed:meshHeadingpubmed-meshheading:10691920...lld:pubmed
pubmed-article:10691920pubmed:meshHeadingpubmed-meshheading:10691920...lld:pubmed
pubmed-article:10691920pubmed:meshHeadingpubmed-meshheading:10691920...lld:pubmed
pubmed-article:10691920pubmed:meshHeadingpubmed-meshheading:10691920...lld:pubmed
pubmed-article:10691920pubmed:year2000lld:pubmed
pubmed-article:10691920pubmed:articleTitleInterferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection.lld:pubmed
pubmed-article:10691920pubmed:affiliationSection of Clinical Immunology and Infectious Diseases and Research Institute for Internal Medicine, Medical Department, Rikshospitalet, Oslo, Norway. eva.stylianou@klinmed.uio.nolld:pubmed
pubmed-article:10691920pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10691920pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10691920lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10691920lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10691920lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10691920lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10691920lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10691920lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10691920lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10691920lld:pubmed